Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Gbi Biomanufacturing Appoints Chandra Kelley As Chief Business Officer

PRIVATEMay 27, 2026•21 days ago

Position

Chief Business Officer

Company

GBI BioManufacturing

Chandra Kelley
PlantationManufacturingBiotechnology

Description

GBI Biomanufacturing announced the appointment of Chandra Kelley as Chief Business Officer (CBO). In her new role, Kelley will lead the company's commercial strategy and long-term growth planning as GBI continues to expand its capabilities.

Company Information

Company

GBI BioManufacturing

Location

Plantation, Florida, United States

About

GBI is a uniquely qualified and flexible US–based CDMO (contract development and manufacturing organization) that offers a Single Source SolutionTM to enhance the value of complex biopharmaceuticals for our clients. With over 30 years of experience as an independent contract manufacturer, GBI has worked as a strategic partner with companies and medical institutions of all sizes, taking their products through clinical trials and towards rapid commercialization. GBI provides process development and cGMP manufacturing services encompassing drug substances and drug products for complex biologics, including multi-specific antibodies, recombinant proteins, antibody- conjugates, and other biologic products. For more information, please visit https://www.gbibio.com/ orContact: info@gbibio.com

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for GBI BioManufacturing's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.